See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Donald Trump
Social Media
Artificial Intelligence
Stock Markets
Music
Natural Disasters
Immigration
Housing
Innovation
Property
MLB
Floods
Published • loading... • Updated

Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication ...

Summary by The Manila Times
– Absence of neurotoxicity of any grade in low-volume disease to-date –

4 Articles

Hastings TribuneHastings Tribune
Center

Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication ...

– Absence of neurotoxicity of any grade in low-volume disease to-date –

Read Full Article
Globe NewswireGlobe Newswire
Reposted by
The Manila TimesThe Manila Times
Center

Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion

– Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in...

Read Full Article
immixbio.comimmixbio.com

Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion - IMMIX BIOPHARMA INC

Open the article to view the coverage from immixbio.com

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Globe Newswire broke the news in on Friday, July 11, 2025.
Sources are mostly out of (0)

Similar News Topics

News
For You
SearchBlindspotLocal